Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  ProMIS Neurosciences, Inc.    PMN   CA74346M1095

PROMIS NEUROSCIENCES, INC.

(PMN)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
All news about PROMIS NEUROSCIENCES, INC.
11/17PROMIS NEUROSCIENCES : Completes offering of special warrants
AQ
11/16PROMIS NEUROSCIENCES : Completes Offering of Special Warrants
AQ
11/16ProMIS Neurosciences Completes Offering of Special Warrants
GL
11/16PROMIS NEUROSCIENCES : Completes offering of special warrants
PU
11/11PROMIS NEUROSCIENCES : Announces Third Quarter 2020 Results
PU
11/11PROMIS NEUROSCIENCES : Announces Third Quarter 2020 Results
AQ
11/11PROMIS NEUROSCIENCES : Announces Third Quarter 2020 Results
AQ
11/11ProMIS Neurosciences Announces Third Quarter 2020 Results
GL
11/09PROMIS NEUROSCIENCES : offers comments on recent FDA Advisory Committee meeting ..
PU
11/09PROMIS NEUROSCIENCES : offers comments on recent FDA Advisory Committee meeting ..
AQ
11/09PROMIS NEUROSCIENCES : offers comments on recent FDA Advisory Committee meeting ..
AQ
11/09ProMIS Neurosciences offers comments on recent FDA Advisory Committee meeting..
GL
11/05PROMIS NEUROSCIENCES : Closes first tranche of private placement
PU
11/05PROMIS NEUROSCIENCES : Closes First Tranche of Private Placement
AQ
11/05ProMIS Neurosciences Closes First Tranche of Private Placement
GL
11/02PROMIS NEUROSCIENCES : Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Research S..
AQ
10/30PROMIS NEUROSCIENCES : adds Dr. David Wishart to its Scientific Advisory Board
AQ
10/30PROMIS NEUROSCIENCES : rsquo; Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Res..
AQ
10/30PROMIS NEUROSCIENCES : rsquo; Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Res..
AQ
10/30ProMIS Neurosciences' Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Research..
GL
10/29PROMIS NEUROSCIENCES : adds Dr. David Wishart to its Scientific Advisory Board
PU
10/29PROMIS NEUROSCIENCES : adds Dr. David Wishart to its Scientific Advisory Board
AQ
10/29PROMIS NEUROSCIENCES : adds Dr. David Wishart to its Scientific Advisory Board
AQ
10/29ProMIS Neurosciences adds Dr. David Wishart to its Scientific Advisory Board
GL
10/26PROMIS NEUROSCIENCES : Announces up to $3 million private placement offering of ..
AQ
10/23PROMIS NEUROSCIENCES : Announces up to $3 million private placement offering of ..
PU
10/23PROMIS NEUROSCIENCES : Announces Up to $3 Million Private Placement Offering of ..
AQ
10/23ProMIS Neurosciences Announces Up to $3 Million Private Placement Offering of..
GL
10/21PROMIS NEUROSCIENCES' PERSPECTIVE ON : is approval likely?
PU
10/21PROMIS NEUROSCIENCES : Offers its Perspective on the Likelihood of Regulatory Ap..
AQ
10/21PROMIS NEUROSCIENCES : Offers its Perspective on the Likelihood of Regulatory Ap..
AQ
10/21ProMIS Neurosciences Offers its Perspective on the Likelihood of Regulatory A..
GL
10/14PROMIS NEUROSCIENCES : Neil Cashman to Speak at Protein Misfolding Drug Discover..
AQ
10/13PROMIS NEUROSCIENCES : rsquo; Neil Cashman to Speak at Protein Misfolding Drug D..
AQ
10/13PROMIS NEUROSCIENCES : rsquo; Neil Cashman to Speak at Protein Misfolding Drug D..
AQ
10/13ProMIS Neurosciences' Neil Cashman to Speak at Protein Misfolding Drug Disco..
GL
09/23PROMIS NEUROSCIENCES : to develop multivalent vaccine for Alzheimer's disease
AQ
09/22PROMIS NEUROSCIENCES : to develop multivalent vaccine for Alzheimer's disease
PU
09/22PROMIS NEUROSCIENCES : to develop multivalent vaccine for Alzheimer's disease
AQ
09/22PROMIS NEUROSCIENCES : to develop multivalent vaccine for Alzheimer's disease
AQ
09/22ProMIS Neurosciences to develop multivalent vaccine for Alzheimer's disease
GL
09/10PROMIS NEUROSCIENCES : to Participate in H.C. Wainwright & Co. 22nd Annual Inves..
AQ
09/10PROMIS NEUROSCIENCES : to Participate in H.C. Wainwright & Co. 22nd Annual Inves..
AQ
09/10ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 22nd Annual Inve..
GL
08/13ProMIS Neurosciences Announces Second Quarter 2020 Results
GL
08/11PROMIS NEUROSCIENCES : CEO memorandum to ProMIS shareholders, August 11, 2020
PU
07/29ProMIS Neurosciences Announces Results of Annual Meeting of Shareholders
GL
07/10PROMIS NEUROSCIENCES : and BC Neuroimmunology announce revenue-sharing joint ven..
AQ
07/09ProMIS Neurosciences and BC Neuroimmunology announce revenue-sharing joint ve..
GL
06/24ProMIS Neurosciences announces adjournment and change of location of annual m..
GL
06/17ProMIS Neurosciences and collaborator BC Neuroimmunology announce significant..
GL
05/28ProMIS Neurosciences and collaborative team receive Supercluster Award suppor..
GL
05/21PROMIS NEUROSCIENCES : Chairman's Update details new programs from expanded use ..
AQ
05/20PROMIS NEUROSCIENCES : and BC Neuroimmunology expand collaboration to develop an..
AQ
05/20PROMIS NEUROSCIENCES : Chairman's Memorandum, May 20, 2020
PU
05/20ProMIS Neurosciences Chairman's Update details new programs from expanded use..
GL
05/19ProMIS Neurosciences and BC Neuroimmunology expand collaboration to develop a..
GL
05/13ProMIS Neurosciences Announces First Quarter 2020 Results
GL
05/12ProMIS Neurosciences identifies multiple novel targets on SARS CoV-2 for deve..
GL
05/06ProMIS Neurosciences develops novel antagonists for RACK1, a protein involved..
GL
04/30ProMIS Neurosciences creates novel intrabodies for ALS, frontotemporal dement..
GL
04/22PROMIS NEUROSCIENCES : commends Biogen for clarifying aducanumab regulatory fili..
AQ
04/15ProMIS Neurosciences announces collaboration to develop serological test to a..
GL
04/10PROMIS NEUROSCIENCES : Journal of the American Academy of Neurology Publishes Pr..
AQ
04/09PROMIS NEUROSCIENCES : Journal of the American Academy of Neurology Publishes Pr..
AQ
04/09Journal of the American Academy of Neurology Publishes ProMIS Neurosciences' ..
GL
04/07ProMIS Neurosciences to Present Data and Moderate Session at AAIC 2020
GL
03/24PROMIS NEUROSCIENCES : Announces approval for warrant repricing
AQ
03/18ProMIS Neurosciences Announces Fiscal Year 2019 Annual Results
GL
02/27PROMIS NEUROSCIENCES : initiates Natural History Study of Blood-Based Biomarkers..
AQ
02/26ProMIS Neurosciences Initiates Natural History Study of Blood-Based Biomarker..
GL
02/25ProMIS Neurosciences Announces Gross Proceeds of $1,257,970 Related to the Ex..
GL
02/11ProMIS Neurosciences to Participate in Noble Capital Markets 16th Annual Inve..
GL
02/06ProMIS Neurosciences to Participate in the BIO CEO & Investor Conference
GL
01/29ProMIS Neurosciences Data for Alzheimer's Disease Program Targeting Tau Accep..
GL
1  2  3Next
Upcoming event on PROMIS NEUROSCIENCES, INC.